↓ Archives ↓

“USA Far Exceeds Cuba in Autism Rate: Big Pharma & Acetominophen Blamed?”

Unraveling the Cause of the Autism Epidemic

Webinar Registration

FREE Webinar January 20, 2012

William Shaw, Ph.D., will present “Unraveling the Cause of the Autism Epidemic: Identifying the Single Most Important Factor.”

Why does the economically backward country of Cuba have an autism rate 100 times lower than the “advanced” United States? Why did the rate of autism soar in the early 1980s in the United States but not in Cuba? Could there be a single factor causing autism that is very common in the United States but is almost completely missing in Cuba?

During this webinar, Dr. Shaw will demonstrate how most of the biochemical abnormalities in autism can be tied to one single factor. This is brand new information that has never been presented before.

You will have the opportunity to participate in a concerted effort to reduce the world-wide rate of autism.

There is very limited space for this event. Please do not sign up unless you are committed to attending.

William Shaw, Ph.D., received his Ph.D. in biochemistry and human physiology from the Medical University of South Carolina. He is board certified in the fields of clinical chemistry and toxicology by the American Board of Clinical Chemistry. Dr. Shaw has supervised large endocrinology, nutritional biochemistry, toxicology, and immunology departments in positions at the Centers for Disease Control (CDC) and Smith Kline Laboratories in Atlanta, GA. As the Director of The Great Plains Laboratory, Inc. for Health, Nutrition and Metabolism in Lenexa, Kansas, he specializes in providing diagnostic tools that aid in the diagnosis and treatment of mental health disorders, mitochondrial disorders, neurological diseases, chronic health issues, and immune diseases.

The webinar begins promptly at 5 p.m. PST, 7 p.m. CST, 8 p.m. EST.

Please Note: This webinar is a one-time, live event and will NOT be recorded. Seating is limited to a first come, first serve basis. Log in early to ensure your place, only the first 1,000 participants to log in will be able to view this webinar.

No Comment

Be the first to respond!

Leave a Reply

You must be logged in to post a comment.